Suppliers / Shivalik Rasayan

Shivalik Rasayan

India Updated 9 July 2026

Shivalik Rasayan is an API manufacturer based in India. It holds 2 active US drug master files and 6 valid CEPs across a filed portfolio of 8 molecules. Customs aggregates show $14K of exports covering 21 molecules to 6 destinations in 2025.

2
active US DMFs
6
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
New Delhi, India Not on file
Bharuch, India 3020983424

What they file, and where

Molecule Regulators Docs
Ambroxol EDQM 1
Bortezomib US FDA 1
Busulfan EDQM 1
Clonidine EDQM 1
Palbociclib US FDA 1
Pemetrexed Disodium EDQM 1
Pirfenidone EDQM 1
Temozolomide EDQM 1

Also appears on these molecule pages

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $19K 3
2025 Not reported $14K 6
2024 Not reported $24K 3
2023 Not reported $56K 2

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Shivalik Rasayan comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts